TE Tirzepatide Editorial

Tool

Tirzepatide Pharmacy Verification Search

Released: · Last reviewed:

Direct answer

This tool generates the verification checklist for a compounding pharmacy: what to ask your provider, which state board record to check, and what each answer establishes. It does not contain a pharmacy database, because no provider-pharmacy relationship in our dataset has been verified — the checks are ones you perform yourself.

Key takeaways

  • This is a verification workflow, not a pharmacy database — no verified records exist yet.
  • State boards of pharmacy publish licence status and disciplinary actions publicly.
  • The four checks are legal name, licence status, facility type, and disciplinary history.
  • A provider that will not name its pharmacy before payment prevents all four checks.
  • This tool runs in your browser; nothing you enter is transmitted or stored.
Key facts
What it producesA verification checklist for a named pharmacy
Pharmacy database includedNo — no verified records exist
Checks coveredLegal name, licence status, facility type, disciplinary history
Verification sourceState boards of pharmacy
Data handlingRuns entirely in your browser
Verified
Medical reviewers Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Released 2026-07-22
Updated
Price verified 2026-09-04
Methodology v4.1
Note. This calculator runs entirely in your browser. No values you enter are transmitted or stored.

Build your verification checklist

Why is there no pharmacy database here?

Because a database whose entries have not been verified is worse than none — it converts unverified information into apparent verification purely by formatting. No provider-pharmacy relationship in our dataset has been confirmed first-party, so there is nothing verified to publish.

The verification method is published instead, at pharmacy verification, because it is something you can complete in a few minutes.

What does each check establish?

The legal name lets you look up an entity rather than a brand. Licence status confirms current authorisation to operate. The 503A or 503B distinction determines which regulatory framework applies. Disciplinary history reveals prior regulatory findings. None of them verify the specific vial you receive — that is not consumer-checkable — but together they establish whether you are dealing with a licensed operation in good standing.

Related: Verification method · 503A versus 503B

What do the verified rates look like?

Mondae$114NexLife$115TRYM Health$125Eden$129Sprout Health$149He & She MD$159Bodybuilding Health+$174.67TelePep$214Yucca Health$225Join Josie$233.25Found$239Pallas Health$239Fridays$240Enhance.MD$280Zappy Health$299
The lowest monthly figure each program prints on a standing plan, November 8, 2026. A low monthly figure usually requires prepaying 6 or 12 months; compare the twelve-month cost in the index before choosing.
Data for: Lowest standing monthly figure per program
ProgramAmount
Mondae$114
NexLife$115
TRYM Health$125
Eden$129
Sprout Health$149
He & She MD$159
Bodybuilding Health+$174.67
TelePep$214
Yucca Health$225
Join Josie$233.25
Found$239
Pallas Health$239
Fridays$240
Enhance.MD$280
Zappy Health$299

What does this page cover, and what does it deliberately leave out?

This page addresses Identity, license, facility, inspections and recalls and discipline, organised around the primary question of tirzepatide pharmacy lookup. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.

Scope of this page and the basis for each element
ElementTreatment hereEvidence basis
IdentityCovered on this pageRegulatory or policy source
LicenseCovered on this pageRegulatory or policy source
FacilityCovered on this pageRegulatory or policy source
InspectionsCovered on this pageRegulatory or policy source
Recalls and disciplineCovered on this pageRegulatory or policy source
Individualized clinical instructionDeliberately not coveredBelongs with the provider's own quotation

What are the limits of what this page can tell you?

Every page on this site rests on a specific figures you enter, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.

Specific limitations.
  • The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the provider's own quotation.
  • Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
  • Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
  • Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.

What would change the conclusion on this page?

Any of the following would change what this page concludes:

  • New primary evidence bearing directly on tirzepatide pharmacy lookup.
  • A change to FDA labelling affecting any statement made above.
  • A verified correction submitted through the corrections process and accepted on the evidence.
  • A material change to a captured record, including a price, term, or regulatory status.
  • Completion of a verification currently marked pending, which would replace a gap with a stated fact.

What do the technical terms on this page mean?

Definitions for the 4 technical terms this page uses, including 503A, 503B, beyond-use date, mg/mL — in the specific sense used above.

Terms used on this page
503AA pharmacy that compounds patient-specific preparations against individual prescriptions. It is licensed by a state board of pharmacy and is not subject to the same federal manufacturing requirements as a 503B facility.
503BAn outsourcing facility that may compound in larger batches without individual prescriptions. It registers with the FDA and is subject to current good manufacturing practice requirements, though registration is still not product approval.
beyond-use dateThe date after which a compounded preparation should not be used. It is assigned by the compounding pharmacy based on its own conditions, and is typically much shorter than a manufacturer expiry date derived from formal stability testing.
mg/mLMilligrams of drug per millilitre of liquid — the concentration. Two vials containing the same nominal dose can require different injection volumes if their concentrations differ, which is why this site does not publish volume calculations.

Frequently asked questions

Does this tool search a pharmacy database?

No. It generates the checklist you use against state board records, because no verified pharmacy records exist in our dataset.

Where do I actually verify a licence?

The relevant state board of pharmacy's licence verification tool and disciplinary actions list.

What if my provider won't name the pharmacy?

Then none of these checks are possible before payment, which is itself a meaningful finding.

Is what I type stored?

No. The tool runs in your browser only.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Change history

Substantive changes to this page
DateChange
2026-07-22Page published with current dataset snapshot.
2026-09-04Shared cost components and disclosures rebuilt from the 2026-09-04 dataset (NexLife September 2026 card re-read live; Yucca Health and a program since removed from this site added; NexLife disclosed as a commercial partner, labelled where it appears).
2026-11-08Updated for November 2026: prices, methodology labels (v4.1) and disclosures brought to the November 8, 2026 dataset; researcher and both medical reviewers named.

Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.

What else is in this section?